drugset / Trial / NCT00757731
FMS European Long-Term Study
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Investigation of the long-term (12 months) efficacy and safety of milnacipran used in the treatment of fibromyalgia syndrome.
Timeline
- Start
- 2006-09
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Milnacipran | Other / unclassified | 100 mg | — |
| Subject | Milnacipran | Other / unclassified | 150 mg | — |
| Subject | Milnacipran | Other / unclassified | 200 mg | — |